HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Non-animal testing bill requires federal agencies to accept alternative in vitro methods.

This article was originally published in The Rose Sheet

Executive Summary

NON-ANIMAL TESTING BILL REQUIRES FEDERAL AGENCY ACCEPTANCE OF IN VITRO METHODS as alternatives to animal testing unless an agency meets certain criteria outlined in the legislation. The ICCVAM Authorization Act (HR 3946) would mandate that all federal bureaus, including FDA, the Environmental Protection Agency and the National Institutes of Health, review and adopt "any formal recommendations" on in vitro toxicological testing protocols proposed by the Inter-Agency Coordinating Committee for the Validation of Alternative Methods "to promulgate new regulations or draft new guidelines" regarding non-animal testing methods. Agencies would have 180 days to respond to ICCVAM once the committee made a final recommendation on an alternative method.
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS005466

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel